| [1] |
de’Angelis N, Abdalla S, Lizzi V, et al. Incidence and predictors of portal and splenic vein thrombosis after pure laparoscopic splenectomy[J]. Surgery, 2017, 162(6): 1219-1230.
|
| [2] |
Wu S, Wu Z, Zhang X, et al. The incidence and risk factors of portal vein system thrombosis after splenectomy and pericardial devascularization[J]. Turk J Gastroenterol, 2015, 26(5): 423-428.
|
| [3] |
Slesser A, Simillis C, Goldin R, et al. A meta-analysis comparing simultaneous versus delayed resections in patients with synchronous colorectal liver metastases[J]. Surg Oncol, 2013, 22(1): 36-47.
URL
|
| [4] |
徐锋, 王超, 唐斌, 等. 低分子肝素钙联合右旋糖酐预防门静脉高压症脾切除术后早期门静脉血栓形成[J]. 中华普通外科杂志, 2016, 31(11): 936-939.
|
| [5] |
Kuroki T, Kitasato A, Tokunaga T, et al. Predictors of portal and splenic vein thrombosis after laparoscopic splenectomy: a retrospective analysis of a single-center experience[J]. Surg Today, 2018, 48(8): 804-809.
|
| [6] |
Basit SA, Stone CD, Gish R. Portal vein thrombosis[J]. Clin Liver Dis, 2015, 19(1): 199-221.
|
| [7] |
Wang H, Kopac D, Brisebois R, et al. Randomized controlled trial to investigate the impact of anticoagulation on the incidence of splenic or portal vein thrombosis after laparoscopic splenectomy[J]. Can J Surg, 2011, 54(4): 227-231.
URL
|
| [8] |
Zhe C, Jian-wei L, Jian C, et al. Laparoscopic versus open splenectomy and esophagogastric devascularization for bleeding varices or severe hypersplenism: a comparative study[J]. J Gastrointest Surg, 2013, 17(4): 654-659.
URL
|
| [9] |
Jiang GQ, Xia BL, Chen P, et al. Anticoagulation therapy with warfarin versus low-dose aspirin prevents portal vein thrombosis after laparoscopic splenectomy and azygoportal disconnection[J]. J Laparoendosc Adv Surg Tech A, 2016, 26(7): 517-523.
|
| [10] |
Zhang Y, Wen TF, Yan LN, et al. Preoperative predictors of portal vein thrombosis after splenectomy with periesophagogastric devascularization[J]. World J Gastroenterol, 2012, 18(15): 1834-1839.
|
| [11] |
Danno K, Ikeda M, Sekimoto M, et al. Diameter of splenic vein is a risk factor for portal or splenic vein thrombosis after laparoscopic splenectomy[J]. Surgery, 2009, 145(5): 457-464; discussion 465-456.
|
| [12] |
Stine J, Wang J, Shah P, et al. Decreased portal vein velocity is predictive of the development of portal vein thrombosis: A matched case-control study[J]. Liver Int, 2018, 38(1): 94-101.
|
| [13] |
牟思玉, 杨哲, 吴力群, 等. 肝硬化门静脉高压脾切除术后门静脉血栓形成的预测因素分析[J]. 临床肝胆病杂志, 2018, 34(1): 106-111.
|
| [14] |
吴晓峰, 伏志, 刘召波, 等. 肝硬化门静脉高压患者行脾切除断流术后早期门静脉血栓形成的原因分析[J]. 临床肝胆病杂志, 2015, 31(3): 400-403.
|
| [15] |
Loffredo L, Pastori D, Farcomeni A, et al. Effects of anticoagulants in patients with cirrhosis and portal vein thrombosis: A systematic review and meta-analysis[J]. Gastroenterology, 2017, 153(2): 480-487.
|
| [16] |
Qi X, Han G, Ye C, et al. Splenectomy causes 10-fold increased risk of portal venous system thrombosis in liver cirrhosis patients[J]. Med Sci Monit, 2016, 22: 2528-2550.
|
| [17] |
姜德清, 黄继超, 安雪霞, 等. 脾切除断流术后门静脉血液流变学变化与门静脉血栓形成关系研究[J]. 中华普通外科杂志, 2011, 26(12): 1045-1046.
|
| [18] |
Kawanaka H, Akahoshi T, Itoh S, et al. Optimizing risk stratification in portal vein thrombosis after splenectomy and its primary prophylaxis with antithrombin III concentrates and danaparoid sodium in liver cirrhosis with portal hypertension[J]. J Am Coll Surg, 2014, 219(5): 865-874.
|
| [19] |
Zocco MA, Di Stasio E, De Cristofaro R, et al. Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development[J]. J Hepatol, 2009, 51(4): 682-689.
URL
|
| [20] |
卢翔, 赵青川, 韩国宏, 等. 肝硬化门静脉高压症术后门静脉血栓形成危险因素研究[J]. 中国实用外科杂志, 2013, 33(3): 205-207.
|
| [21] |
Wang L, Liu GJ, Chen YX, et al. Combined use of D-dimer and P-selectin for the diagnosis of splenic or portal vein thrombosis following splenectomy[J]. Thromb Res, 2010, 125(5): e206-e209.
|
| [22] |
魏云海, 慎华平, 张国雷, 等. 监测P-选择素、血栓前体蛋白、D-二聚体对门脉高压脾切除术后门静脉血栓形成的早期预测价值[J]. 中华肝胆外科杂志, 2013, 19(7): 526-529.
|
| [23] |
Jiang GQ, Bai DS, Chen P, et al. Risk factors for portal vein system thrombosis after laparoscopic splenectomy in cirrhotic patients with hypersplenism[J]. J Laparoendosc Adv Surg Tech A, 2016, 26(6): 419-423.
|
| [24] |
Chawla YK, Bodh V. Portal vein thrombosis[J]. J Clin Exp Hepatol, 2015, 5(1): 22-40.
|
| [25] |
Qi X, Ren W, De Stefano V, et al. Associations of coagulation factor V Leiden and prothrombin G20210A mutations with Budd-Chiari syndrome and portal vein thrombosis: a systematic review and meta-analysis[J]. Clin Gastroenterol Hepatol, 2014, 12(11): 1801-1812.
|
| [26] |
Ayala R, Grande S, Bustelos R, et al. Obesity is an independent risk factor for pre-transplant portal vein thrombosis in liver recipients[J]. BMC Gastroenterol, 2012, 12: 114.
|
| [27] |
Yerdel MA, Gunson B, Mirza D, et al. Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome[J]. Transplantation, 2000, 69(9): 1873-1881.
|
| [28] |
张丽娟. 肝硬化门静脉高压症外科手术后门静脉血栓形成的危险因素分析[J]. 实用临床医药杂志, 2016, 20(17): 71-73.
|
| [29] |
邓美海, 邓鹏, 刘波, 等. D-二聚体对门静脉高压症术后门静脉血栓形成的早期预测价值[J]. 中华实验外科杂志, 2006, 23(11): 1293-1295.
|
| [30] |
李大伟. 血浆D-二聚体对腹腔镜脾切除门奇静脉断流术后门静脉血栓形成的预测意义[J]. 中国普通外科杂志, 2014, 23(2): 207-211.
URL
|
| [31] |
袁博, 李欢送. 血栓弹力图在肝硬化脾切除术后预防门静脉血栓中的应用[J]. 河北医学, 2018, 24(1): 83-86.
|
| [32] |
Margini C, Berzigotti A. Portal vein thrombosis: The role of imaging in the clinical setting[J]. Dig Liver Dis, 2017, 49(2): 113-120.
|
| [33] |
蒋国庆, 柏斗胜, 钱建军, 等. 华法林防治改良腹腔镜脾切除联合贲门周围血管断流术后门静脉血栓的临床疗效[J]. 中华消化外科杂志, 2016, 15(1): 71-74.
|
| [34] |
Cheng Z, Yu F, Tian J, et al. A comparative study of two anti-coagulation plans on the prevention of PVST after laparoscopic splenectomy and esophagogastric devascularization[J]. J Thromb Thrombolysis, 2015, 40(3): 294-301.
|
| [35] |
牛秀峰, 高林, 倪家连, 等. 脾切除断流术后经脾静脉抗凝治疗预防早期门静脉血栓的安全性分析[J]. 肝胆胰外科杂志, 2012, 24(1): 27-29.
|
| [36] |
李晓军. 门静脉置管抗凝预防脾切除术后门静脉血栓形成45例临床分析[J]. 中国医师进修杂志, 2009, 32(s1): 121-122.
|
| [37] |
杨学堂. 脾周围韧带和脾蒂解剖在门脉高压症脾切除术中的应用[J]. 中国现代药物应用, 2013, 7(4): 23-24.
|
| [38] |
何天时, 李旭宏, 薛浩, 等. 脾动脉灌注与二级脾蒂离断法在门脉高压患者脾切除术中的联合应用[J]. 中华肝胆外科杂志, 2015, 21(8): 565-566.
|
| [39] |
Lai W, Lu SC, Li GY, et al. Anticoagulation therapy prevents portal-splenic vein thrombosis after splenectomy with gastroesophageal devascularization[J]. World J Gastroenterol, 2012, 18(26): 3443-3450.
|
| [40] |
伏志, 王鑫, 张媛媛, 等. 经静脉尿激酶溶栓在治疗门静脉高压症脾切除术后门静脉血栓的疗效观察[J]. 医学研究杂志, 2015, 44(7): 107-109.
|
| [41] |
郑春雷, 赵永福, 唐哲, 等. 早期联合应用抗凝药物预防脾切断流术后门静脉血栓的形成[J]. 世界华人消化杂志, 2015, 23(1): 129-133.
|
| [42] |
Gong C, Qin X, Yang J, et al. The best anticoagulation strategy for cirrhotic patients who underwent splenectomy: A network meta-analysis[J]. Gastroenterol Res Pract, 2017, 2017: 9216172.
|
| [43] |
Lenz K, Dieplinger B, Buder R, et al. Successful treatment of partial portal vein thrombosis (PVT) with low dose rivaroxaban[J]. Zeitschrift Für Gastroenterologie, 2014, 52(10): 1175-1177.
URL
|
| [44] |
Jiang GQ, Bai DS, Chen P, et al. Predictors of portal vein system thrombosis after laparoscopic splenectomy and azygoportal disconnection: A retrospective cohort study of 75 consecutive patients with 3-months follow-up[J]. Int J Surg, 2016, 30: 143-149.
|
| [45] |
Handa P, Crowther M, Douketis JD. Portal vein thrombosis: a clinician-oriented and practical review[J]. Clin Appl Thromb Hemost, 2014, 20(5): 498-506.
|
| [46] |
Lakhoo J, Gaba RC. Outcomes of transjugular intrahepatic portosystemic shunt creation for flow-enabled dissolution of spleno-mesenterico-portal venous thrombosis[J]. Diagn Interv Imaging, 2016, 97(11): 1085-1093.
|
| [47] |
Van Ha TG, Hodge J, Funaki B, et al. Transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis and concomitant portal vein thrombosis[J]. Cardiovasc Intervent Radiol, 2006, 29(5): 785-790.
|